Microchip Technology (MCHP) CEO-linked entities sell 98,814 shares

Rhea-AI Filing Summary

Microchip Technology entities associated with President, CEO and Chair of the Board Steve Sanghi sold 98,814 shares of common stock on January 28, 2026 at an average price of $80.5535 per share. The sale was effected under a Rule 10b5-1 trading plan adopted on June 6, 2025.

After this transaction, these entities beneficially owned a total of 9,922,319 Microchip shares, including 4,016,447 shares held by The Sanghi Trust and 5,905,872 shares held by The Sanghi Family Limited Partnership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sanghi Steve

(Last) (First) (Middle)

C/O MICROCHIP TECHNOLOGY INCORPORATED

2355 WEST CHANDLER BOULEVARD

(Street)

CHANDLER AZ 85224-6199

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROCHIP TECHNOLOGY INC [ MCHP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO and Chair of Bd

3. Date of Earliest Transaction (Month/Day/Year)
01/28/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/28/2026		S(1)		98,814	D	$80.5535	9,922,319	I(2)	Shares held Indirectly, by Trust and by Family Limited Partnership.(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale(s) reported in this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025.

2. Of the 9,922,319 shares held, 4,016,447shares were held by The Sanghi Trust; and 5,905,872 shares were held by The Sanghi Family Limited Partnership.

Remarks:

	Deborah L. Wussler, as Attorney-in-Fact	01/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Microchip Technology (MCHP) report for Steve Sanghi?

The filing reports that entities associated with Steve Sanghi sold 98,814 shares of Microchip common stock. The transaction occurred on January 28, 2026 and was reported as an open-market sale of non-derivative common stock on a Form 4 insider trading report.

At what price were the 98,814 Microchip (MCHP) shares sold in this Form 4?

The 98,814 Microchip common shares were sold at an average price of $80.5535 per share. This price is disclosed directly in the Form 4 as the sale price for the non-derivative common stock transaction dated January 28, 2026.

How many Microchip (MCHP) shares do the Sanghi-related entities own after this sale?

Following the sale, entities associated with Steve Sanghi beneficially owned 9,922,319 Microchip shares. According to the disclosure, 4,016,447 shares are held by The Sanghi Trust and 5,905,872 shares are held by The Sanghi Family Limited Partnership.

Who actually holds the Microchip (MCHP) shares reported in Steve Sanghi’s Form 4?

The filing states that 4,016,447 shares are held by The Sanghi Trust and 5,905,872 shares are held by The Sanghi Family Limited Partnership. These entities collectively hold 9,922,319 shares reported as indirectly owned in connection with Steve Sanghi.

Was the Microchip (MCHP) insider sale made under a Rule 10b5-1 plan?

Yes. The Form 4 explains that the sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2025. This note appears in the footnotes to the transaction table in the filing.

What roles does Steve Sanghi hold at Microchip Technology (MCHP)?

The Form 4 identifies Steve Sanghi as a director and an officer of Microchip Technology. His officer title is listed as President, CEO and Chair of the Board, indicating multiple leadership roles at the company at the time of the reported transaction.